Questions about a product, technology or experimental design? Give us a call 610-644-8845.

AC2005: 17-AAG

Lifesensors AC2005 (17-AAG) is a potent HSP90 inhibitor with 100x higher affinity for tumor cells, used as an autophagy modulator in cancer research and therapy.

$69.00$171.00

Tanespimycin (17-AAG) is a cell permeable, less toxic and more stable semi-synthetic analog of geldanamycin. 17-AAG is a potent HSP90 inhibitor displaying a 100-fold higher affinity for tumor cell derived HSP90 over normal cell HSP90. 17-AAG displays anti-angiogenic activity and sensitizes tumor cells to apoptosis in response to such agents as taxol and cisplatin. Tanespimycin (17-AAG) depletes cellular STK38/NDR1 and reduces STK38 kinase activity. Tanespimycin (17-AAG) also downregulates stk38 gene expression.

Info

Purity >98% by TLC
Quantity 1 mg, 5 mg
Molecular Weight 585.7 g/mol
Physical State Lyophilized red to dark red powder
Solubility >50 mg/ml in DMSO; 5 mg/mL in ethanol
CAS No. 75747-14-7
Storage -20°C, avoid freeze/thaw cycles

send us a message for pricing

CONTACT INFORMATION

Phone (Office)

610.644.8845

SEND EMAIL

info@lifesensors.com

VISIT ANYTIME

271 Great Valley Parkway Malvern, PA 19355

More from This Category

PROTAC IS A REGISTERED TRADEMARK OF ARVINAS OPERATIONS, INC., AND IS USED UNDER LICENSE.